Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


New Technologies Drive Growth In Orthopedic Extremities Market

This article was originally published in Start Up

Executive Summary

While the mature hips, knees, and spine segments of the orthopedics industry are growing by low single-digit rates, some sectors of the extremity industry are growing by 13% to 14%. START-UP profiles three companies in different sectors of extremities: Conventus Orthopaedics, in the hand and wrist market, Nextremity Solutions, working on devices for the forefoot, and Cartiva Medical, with a cartilage platform and an initial focus on the great toe.

You may also be interested in...

Cartiva Inc.

The Cartiva synthetic cartilage implant from Cartiva Inc. is mostly water; hence, the hydrogel polymer mimics physical properties of human cartilage. The company is initially focusing on repairing cartilage defects in ankles and feet, specifically the metatarsophalangeal joint at the base of the great toe, to relieve arthritis pain.

Nextremity Solutions Inc.

Nextremity Solutions Inc. is focusing on devices for the forefoot – treatments for hammertoes and bunions, for example – which, with a projected growth rate of 13% is the fastest growing sector of the foot and ankle market and one of the fastest growing in orthopedic surgery.

Conventus Orthopaedics Inc.

Entering a market dominated by invasive metal plates and screws, the founders of Conventus Orthopaedics Inc., who came from the cardiovascular industry, have adapted the concept of minimally invasive self-expanding stents to the problem of treating distal radius fractures, the most common fracture of the forearm.

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts